Abstract: An insurance management system for a vehicle may include at least one advanced driver-assistance system (ADAS) system of a vehicle configured to provide an indication of activation of the ADAS system, a memory of a vehicle configured to maintain data relating to the vehicle and driver, and a processor of the vehicle configured to receive driver data indicative of driver behavior, the driving behavior indicative of activation of at least one ADAS feature, receive context data relating at least in part to the activation of the ADAS feature, and generate a risk value specific to the driver and the vehicle based at least in part on the context data and the activation of the at least one ADAS feature.

Abstract: The present invention relates to sodium channel inhibitors of Formula I: in which R1, R2, R3, R4, R5, R6, and R7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.

Abstract: The present invention relates to sodium channel inhibitors of Formula I: in which R1, R2, R3, R4, R5, R6, and R7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.

Abstract: The present invention relates to sodium channel inhibitors of Formula I: in which R1, R2, R3, R4, R5, R6, and R7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.

Abstract: The present invention relates to sodium channel inhibitors of Formula : in which R1, R2, R3, R4, R5, R6, and R7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.

Abstract: Devices and methods for sterilizing lumens involve a booster that is attached to the lumen. In preferred embodiments, the contact area between the lumen and the booster enhances the penetration of an antimicrobial agent to the contact area.

Abstract: Disclosed herein are methods of sterilizing a device in a sterilizer, methods of sterilizing a device in an enclosure in a sterilizer, and enclosures for retaining a device capable of being sterilized in a sterilization process. The sterilization process comprises hydrogen peroxide vapor or gas. The sterilization load may include an enclosure, which can be a tray or a container. The tray or container comprises at least a volume of aluminum oxide. The ratio of the amount of hydrogen peroxide gas or vapor introduced into the sterilizer to the volume of aluminum oxide is at least 24 mg/cm3.

Abstract: Disclosed herein are methods of sterilizing a device in a sterilizer, methods of sterilizing a device in an enclosure in a sterilizer, and enclosures for retaining a device capable of being sterilized in a sterilization process. The sterilization process comprises hydrogen peroxide vapor or gas. The sterilization load may include an enclosure, which can be a tray or a container. The tray or container comprises at least a volume of aluminum oxide. The ratio of the amount of hydrogen peroxide gas or vapor introduced into the sterilizer to the volume of aluminum oxide is at least 24 mg/cm3.